翻訳と辞書
Words near each other
・ Delaney Williams
・ Delaney, California
・ Delaney, West Virginia
・ Delaneys Creek, Queensland
・ Delaneys Falls
・ DeLange
・ Delacău, Transnistria
・ Deladar
・ Delaf
・ Delafield
・ Delafield (town), Wisconsin
・ Delafield Fish Hatchery
・ Delafield Township, Jackson County, Minnesota
・ Delafield, Illinois
・ Delafield, Wisconsin
Delafloxacin
・ Delaford River
・ Delafosse
・ Delafossite
・ DELAG
・ Delage
・ Delage (band)
・ Delage 12C.E.D.irs
・ Delage D4
・ Delage D6
・ Delage D8
・ Delah Khani
・ Delahaie
・ Delahanty
・ Delahaye


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Delafloxacin : ウィキペディア英語版
Delafloxacin

Delafloxacin (originally RX-3341) is a fluoroquinolone antibiotic being developed by Rib-X Pharmaceuticals, Inc.
It is more active (lower MIC90) than other quinolones against Gram-positive bacteria such as MRSA. In contrast to most approved fluoroquinolones, which are zwitterionic, delafloxacin has an anionic character, which results in a 10-fold increase in delafloxacin accumulation in both bacteria and cells at acidic pH. This property is believed to confer to delafloxacin an advantage for the eradication of ''Staphylococcus aureus'' in acidic environments, including intracellular infections.〔Lemaire, S. et al. (''Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus'' ) Antimicrob. Agents Chemother. February 2011; 55:649-658 doi:10.1128/AAC.01201-10〕
==Clinical trials==
Phase II clinical trials have been completed,〔http://www.bio-medicine.org/biology-technology-1/Rib-X-Pharmaceuticals-Announces-Positive-Phase-2-Study-Results-for-Delafloxacin-and-a--2425-Million-Financing-10093-1/〕〔http://clinicaltrials.gov/ct2/show/NCT00719810〕〔http://www.medicalnewstoday.com/articles/132200.php "Rib-X Pharmaceuticals Reports Positive Top-Line Results From Phase 2 Study Of Delafloxacin" 9 Dec 2008〕 including a trial with tigecycline as a comparator〔http://www.citybizlist.com/lstg/lstgDetail.aspx?id=45749 "ABS Ventures Joins $25M Series D Rib-X Pharmaceuticals Inc." 5 Feb 2009〕 The company states delafloxacin met its primary and secondary efficacy endpoints based on the draft guidance from the FDA.
A Phase III trial for acute bacterial skin and skin structure infections (ABSSSI) is due to begin in the 2nd half of 2012.〔(Delafloxacin - Pipeline ) - Rib-X Pharmaceuticals. Accessed: 6/27/2012.〕

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Delafloxacin」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.